532612 announcements Indoco Rem announcements and dividends declared BSE
Indoco Rem Complete list of announcements declared & dividend announcements by Indoco Rem 532612
Indoco Rem 532612 listed on BSE and deals inAnnouncements and dividends declared by Indoco Rem 532612
Indoco Remedies gets warning letter from USFDA for Goa plant
Indoco Remedies' Goa plant received a warning letter from the USFDA following a July inspection. The company stated its commitment to resolving the issues and maintaining compliance with US regulations while continuing to supply products to the US market.
Announcement as on 17 December 2024
Indoco Remedies update on USFDA inspection of its facilities in Goa
Indoco Remedies has received regulatory status from U.S. Food and Drug Administration (USFDA), for its facilities located at Goa Plant-II & III, L-32,33,34, Verna Industrial Area, Verna, Goa, Goa 403722, India (Facility), following an inspection conducted
Announcement as on 11 October 2024
Indoco Remedies receives USFDA approval for Cetirizine Hydrochloride Tablets
Indoco Remedies (Indoco) announced the receipt of final approval from the USFDA for Abbreviated New Drug Application (ANDA) for Cetirizine Hydrochloride Tablets USP, 10 mg (OTC), a generic equivalent of the Reference Listed Drug, Zyrtec Allergy Tablets, 10
Announcement as on 04 October 2024
Indoco Remedies shares rise over 3% on USFDA nod for allergy drug
Mumbai based pharmaceutical company Indoco Remedies share price surged 3.13 per cent at Rs 349.95 per share on the BSE
Announcement as on 04 October 2024
Indoco Remedies gets USFDA nod to market Lofexidine tablets with 180 days exclusivity
Indoco Remedies Ltd was granted approval from the USFDA to sell its generic Lofexidine tablets, used for opioid withdrawal. This approval includes 180 days of market exclusivity. The company plans an immediate US launch, manufacturing the product in Goa. E
Announcement as on 21 August 2024
Announcements by Indoco Rem first page | Next page |
532612 Indoco Rem current price & indicator signals
Recent prices of 532612 Indoco Rem are as follows: Daily volume is divided by 10 day averaged volume
Date | Close | Range | Change % | Volume |
09 Thu Jan 2025 | 335.00 | 325.50 to 342.35 | -0.37% | 0.81 times |
08 Wed Jan 2025 | 336.25 | 332.25 to 337.00 | -0.04% | 1.74 times |
07 Tue Jan 2025 | 336.40 | 334.20 to 337.95 | 0.75% | 0.68 times |
06 Mon Jan 2025 | 333.90 | 331.95 to 340.05 | -0.7% | 0.88 times |
03 Fri Jan 2025 | 336.25 | 335.20 to 343.60 | -0.49% | 2.81 times |
02 Thu Jan 2025 | 337.90 | 332.65 to 340.20 | 1.79% | 0.77 times |
01 Wed Jan 2025 | 331.95 | 331.05 to 334.35 | -0.84% | 0.44 times |
31 Tue Dec 2024 | 334.75 | 323.80 to 336.85 | 1.66% | 0.3 times |
30 Mon Dec 2024 | 329.30 | 326.05 to 338.90 | -0.87% | 1.25 times |
27 Fri Dec 2024 | 332.20 | 329.20 to 332.95 | -0.09% | 0.68 times |
26 Thu Dec 2024 | 332.50 | 326.10 to 334.25 | 0.73% | 0.46 times |
24 Tue Dec 2024 | 330.10 | 326.10 to 341.40 | 0.17% | 1.11 times |
Videos related to: 532612 announcements Indoco Rem announcements and dividends declared BSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- BSE Screeners
- BSE Daily Screener
- BSE Weekly Screener
- BSE Monthly Screener
- Support & Resistance
- BSE Shares Near Support
- BSE Shares Near Resistance